カルナバイオサイエンスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2010/09/27 | 45,200 | 45,200 | 43,000 | 44,700 | -200 | -0.4% | 106 |
2010/09/24 | 45,000 | 45,000 | 43,000 | 44,900 | -100 | -0.2% | 74 |
2010/09/22 | 45,800 | 46,500 | 43,900 | 45,000 | -600 | -1.3% | 156 |
2010/09/21 | 44,500 | 45,900 | 42,800 | 45,600 | +1,800 | +4.1% | 178 |
2010/09/17 | 41,750 | 43,800 | 41,750 | 43,800 | +2,000 | +4.8% | 101 |
2010/09/16 | 41,900 | 42,650 | 41,350 | 41,800 | +100 | +0.2% | 76 |
2010/09/15 | 41,300 | 42,000 | 41,250 | 41,700 | -50 | -0.1% | 39 |
2010/09/14 | 41,700 | 42,000 | 41,200 | 41,750 | -350 | -0.8% | 81 |
2010/09/13 | 41,600 | 42,500 | 41,250 | 42,100 | +100 | +0.2% | 87 |
2010/09/10 | 42,400 | 43,000 | 41,800 | 42,000 | +300 | +0.7% | 79 |
2010/09/09 | 44,000 | 46,100 | 41,700 | 41,700 | -1,600 | -3.7% | 452 |
2010/09/08 | 41,100 | 43,300 | 40,600 | 43,300 | +2,250 | +5.5% | 153 |
2010/09/07 | 40,500 | 42,900 | 40,300 | 41,050 | +650 | +1.6% | 175 |
2010/09/06 | 40,100 | 40,500 | 40,000 | 40,400 | +350 | +0.9% | 117 |
2010/09/03 | 40,500 | 41,050 | 40,050 | 40,050 | -150 | -0.4% | 149 |
2010/09/02 | 40,450 | 40,600 | 40,000 | 40,200 | -150 | -0.4% | 96 |
2010/09/01 | 40,050 | 40,700 | 39,850 | 40,350 | +150 | +0.4% | 276 |
2010/08/31 | 42,050 | 42,950 | 40,200 | 40,200 | -3,200 | -7.4% | 213 |
2010/08/30 | 44,100 | 44,100 | 42,700 | 43,400 | -700 | -1.6% | 87 |
2010/08/27 | 42,700 | 44,100 | 42,400 | 44,100 | ±0 | ±0% | 49 |
2010/08/26 | 47,000 | 47,000 | 44,000 | 44,100 | -2,350 | -5.1% | 108 |
2010/08/25 | 45,000 | 49,000 | 43,000 | 46,450 | -750 | -1.6% | 481 |
2010/08/24 | 41,500 | 48,400 | 41,100 | 47,200 | +5,800 | +14% | 428 |
2010/08/23 | 40,800 | 41,900 | 40,800 | 41,400 | +600 | +1.5% | 60 |
2010/08/20 | 40,500 | 42,000 | 40,000 | 40,800 | +400 | +1% | 120 |
2010/08/19 | 40,000 | 40,400 | 39,250 | 40,400 | +250 | +0.6% | 46 |
2010/08/18 | 40,000 | 40,300 | 39,800 | 40,150 | +150 | +0.4% | 19 |
2010/08/17 | 39,800 | 41,450 | 39,600 | 40,000 | -950 | -2.3% | 64 |
2010/08/16 | 40,300 | 41,550 | 39,600 | 40,950 | +1,100 | +2.8% | 102 |
2010/08/13 | 40,500 | 41,500 | 39,750 | 39,850 | -150 | -0.4% | 51 |
2010/08/12 | 39,000 | 40,000 | 38,100 | 40,000 | ±0 | ±0% | 143 |
2010/08/11 | 40,000 | 40,100 | 39,350 | 40,000 | +250 | +0.6% | 61 |
2010/08/10 | 40,000 | 40,400 | 39,700 | 39,750 | -150 | -0.4% | 82 |
2010/08/09 | 41,000 | 41,000 | 39,600 | 39,900 | -1,450 | -3.5% | 80 |
2010/08/06 | 40,500 | 41,400 | 40,100 | 41,350 | +1,050 | +2.6% | 74 |
2010/08/05 | 40,300 | 41,000 | 40,300 | 40,300 | ±0 | ±0% | 98 |
2010/08/04 | 40,300 | 41,000 | 40,150 | 40,300 | -900 | -2.2% | 66 |
2010/08/03 | 40,800 | 41,350 | 40,500 | 41,200 | -300 | -0.7% | 98 |
2010/08/02 | 42,200 | 42,200 | 40,700 | 41,500 | -750 | -1.8% | 117 |
2010/07/30 | 42,800 | 43,500 | 41,100 | 42,250 | -1,150 | -2.6% | 152 |
2010/07/29 | 43,700 | 43,700 | 42,700 | 43,400 | -400 | -0.9% | 30 |
2010/07/28 | 43,700 | 43,950 | 42,600 | 43,800 | +300 | +0.7% | 57 |
2010/07/27 | 44,500 | 44,500 | 43,000 | 43,500 | -1,500 | -3.3% | 85 |
2010/07/26 | 46,200 | 46,200 | 44,700 | 45,000 | +50 | +0.1% | 81 |
2010/07/23 | 44,500 | 45,700 | 43,300 | 44,950 | +850 | +1.9% | 91 |
2010/07/22 | 47,300 | 47,300 | 43,800 | 44,100 | -4,200 | -8.7% | 149 |
2010/07/21 | 50,000 | 50,000 | 45,100 | 48,300 | -600 | -1.2% | 277 |
2010/07/20 | 46,800 | 49,200 | 46,300 | 48,900 | +3,500 | +7.7% | 449 |
2010/07/16 | 46,000 | 46,700 | 42,600 | 45,400 | -200 | -0.4% | 271 |
2010/07/15 | 53,000 | 54,400 | 45,000 | 45,600 | -5,400 | -10.6% | 1,223 |
3451~
3500
件表示中 / 3571件
類似銘柄と比較する
現在ご覧いただいている「カルナバイオ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
カルナバイオ | 31,300円 | -43.1% | - | 0.00% | - | 1.86倍 |
|
キナーゼタンパク質の販売や受託試験など創薬初期の支援事業が柱。キナーゼ阻害剤で創薬も |
カイオム | 10,200円 | +2.6% | - | 0.00% | - | 5.90倍 |
|
独自の抗体作製技術を持つ理研発の創薬ベンチャー。医薬品候補抗体導出と技術供与が収益源 |
VIS | 94,000円 | +87.8% | +265.7% | 0.00% | 56.46倍 | 2.59倍 |
|
mRNA標的低分子創薬技術を製薬会社に提供。共同創薬研究などによる契約金収入が柱 |
クリングル | 84,400円 | +14.5% | - | 0.00% | - | 2.49倍 |
|
細胞の増殖、保護、修復などの機能があるHGFタンパク質を用いて、難治性疾患治療薬を開発 |
カイノス | 116,800円 | +6.8% | -13.8% | 2.74% | 8.95倍 | 0.76倍 |
|
臨床検査薬の中堅メーカー。生化学、免疫血清学的検査用試薬に重点。共同開発の促進に注力 |
市場注目の銘柄
チャート関連のコラム